-transparent.png){kind=logo}
Cis-diamminedichloroplatinum has been proven to be an effective neoplastic agent. Nephrotoxicity and ototoxicity are two prominent side effects of this drug. Investigation of ototoxicity has been limited to auditory function. This report details the first known case of vestibular toxicity following platinum therapy. In addition, a prospective vestibular testing program is reported.
Related Publications
S D Schaefer, and
C G Wright, and
J D Post, and
E P Frenkel
October 1981,
American journal of obstetrics and gynecology,
S D Schaefer, and
C G Wright, and
J D Post, and
E P Frenkel
May 1985,
The New Zealand medical journal,
S D Schaefer, and
C G Wright, and
J D Post, and
E P Frenkel
June 1981,
Chemico-biological interactions,
S D Schaefer, and
C G Wright, and
J D Post, and
E P Frenkel
March 1986,
British journal of cancer,
S D Schaefer, and
C G Wright, and
J D Post, and
E P Frenkel
July 1983,
Cancer,
S D Schaefer, and
C G Wright, and
J D Post, and
E P Frenkel
June 2012,
Toxicology letters,
S D Schaefer, and
C G Wright, and
J D Post, and
E P Frenkel
October 1983,
Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery,
S D Schaefer, and
C G Wright, and
J D Post, and
E P Frenkel
December 1987,
Cancer treatment reviews,
S D Schaefer, and
C G Wright, and
J D Post, and
E P Frenkel
January 1991,
Oncology,
S D Schaefer, and
C G Wright, and
J D Post, and
E P Frenkel
January 1982,
Anticancer research,
